TickerFacts.

Company research / BAX

Baxter International Inc (BAX)

Build a valuation ↗↓ Download CSV

SEC name BAXTER INTERNATIONAL INC · CIK 0000010456 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Baxter International Inc reported revenue of $11.24B. Revenue grew 5.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $11.47B.

Key ratios (year ended 2025-12-31)

30.1%
Gross margin
-2.7%
Operating margin
-8.5%
Net margin
-15.7%
Return on year-end equity
5.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-03

Headquarters locality: Deerfield · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312019-06-302019-03-312018-12-31
Revenue$11.47B$11.24B$10.64B$10.36B$10.06B$12.15B$11.67B$11.36Bn/an/a$11.10B
Cost of Revenue$8.02B$7.87B$6.65B$6.21B$6.51B$7.43B$7.09B$6.60Bn/an/a$6.34B
Gross Profit$3.45B$3.38B$3.98B$4.15B$3.55B$4.72B$4.59B$4.76Bn/an/a$4.76B
R&D Expense$512.00M$518.00M$590.00M$518.00M$450.00M$531.00M$521.00M$595.00Mn/an/a$654.00M
Operating Income-$274.00M-$308.00M$14.00M$707.00M-$2.85B$1.35B$1.62B$1.77Bn/an/a$1.58B
Depreciation & Amortization$953.00M$981.00M$997.00M$984.00M$1.07B$867.00M$823.00M$789.00Mn/an/a$771.00M
EBITDA$679.00M$673.00M$1.01B$1.69B-$1.77B$2.22B$2.44B$2.56Bn/an/a$2.35B
Net Income-$1.06B-$957.00M-$649.00M$2.66B-$2.43B$1.28B$1.10B$1.00Bn/an/a$1.55B
EPS (Diluted)n/a-$1.87-$1.27$5.23-$4.83$2.53$2.13$1.93n/an/a$2.83
Total Assets$19.79B$20.05B$25.78B$28.28B$28.29B$33.52B$20.02B$18.19B$17.50B$16.24B$15.72B
Total Liabilities$13.61B$13.95B$18.76B$19.81B$22.39B$24.40B$11.29B$10.28B$9.70B$8.65B$7.85B
Long-Term Debtn/a$9.44B$13.18B$13.86B$16.70B$17.75B$6.23Bn/an/an/an/a
Shareholders' Equity$6.18B$6.10B$7.02B$8.47B$5.89B$9.12B$8.73B$7.91B$7.80B$7.59B$7.87B
Cash & Equivalents$2.15B$1.97B$1.76B$3.08B$1.62B$2.95B$3.73B$3.33B$2.93B$1.90B$1.84B
Operating Cash Flow$1.32B$845.00M$1.02B$1.73B$1.21B$2.22B$1.87B$2.10Bn/an/a$2.02B
Capital Expendituresn/a$513.00M$446.00M$432.00M$377.00M$691.00M$709.00M$696.00Mn/an/a$659.00M
Free Cash Flown/a$332.00M$573.00M$1.29B$834.00M$1.53B$1.16B$1.41Bn/an/a$1.36B
Share Repurchasesn/an/a$0$0$32.00M$600.00M$500.00M$1.27Bn/an/a$2.45B
Dividends Paid$184.00M$348.00M$590.00M$586.00M$573.00M$530.00M$473.00M$423.00Mn/an/a$376.00M
Dividends Per Sharen/a$0.52$1.04$1.16$1.15$1.08$0.95$0.85n/an/a$0.73
Weighted Average Diluted Sharesn/a513.00M510.00M508.00M504.00M508.00M517.00M519.00Mn/an/a546.00M
EPS (Basic)n/a-$1.87-$1.27$5.25-$4.83$2.56$2.17$1.97n/an/a$2.90

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView